Company type
Biotechnology company developing new generation biologics for the treatment of cancer and infectious disease.Funding rounds
| Investor | Profile | Country | |
|---|---|---|---|
| |
Crédit Agricole Private Equity | ||
| |
Forbion Capital Partners | ||
| |
Harris & Harris Group Inc (HHVC) | Internally managed venture capital company specializing in nanotechnology and microsystems | |
| |
Innoven Partenaires SA | ||
| |
New Science Ventures (NSV) | Venture capital firm investing in both early and late stage companies using novel scientific approaches to address significant unmet needs. | |
| |
Scottish Equity Partners LLP (SEP) | ||
| |
Triathlon Medical Ventures LLC |
| Investor | Profile | Country | |
|---|---|---|---|
| |
Avalon Ventures | ||
| |
Beringea LLC | Transatlantic venture capital firm. | |
| |
Excalibur Fund Managers Ltd | ||
| |
GeneChem Management Inc | Venture capital firm targeting companies in the genomics industry | |
| |
Lloyds TSB Development Capital Ltd (LDC) | The private equity arm of Lloyds Banking Group. | |
| |
Morningside Group | ||
| |
MVM Life Science Partners LLP | Venture capital firm which invests in technologies and products for the life science and healthcare markets | |
| |
Omega Fund Management UK LLP | ||
| |
Sectoral Asset Management Inc | ||
| |
Ventech SA | ||
| |
Ysios Capital Partners SGECR SA | Spanish venture capital firm focused on the healthcare space. |
| Investor | Profile | Country | |
|---|---|---|---|
| |
Avalon Ventures | ||
| |
Crédit Agricole Private Equity | ||
| |
Forbion Capital Partners | ||
| |
GeneChem Management Inc | Venture capital firm targeting companies in the genomics industry | |
| |
Innoven Partenaires SA | ||
| |
New Science Ventures (NSV) | Venture capital firm investing in both early and late stage companies using novel scientific approaches to address significant unmet needs. | |
| |
Scottish Equity Partners LLP (SEP) | ||
| |
Triathlon Medical Ventures LLC |
Investment activity status
Active investor